As part of the 863 program, MOST held a review of IVD developments. 40 clinical assays are involved, and about 10 companies are about to register products.
China Bio news release, November 13, 2013-11-13
As part of the 863 program, MOST held a review of IVD developments. 40 clinical assays are involved, and about 10 companies are about to register products.
China Bio news release, November 13, 2013-11-13
This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.
Accept or Deny